Location History:
- Tokyo, JA (1977)
- Hiromachi, JP (1979 - 1998)
- Tokyo, JP (1986 - 1998)
Company Filing History:
Years Active: 1977-1998
Title: Atsusuke Terada: A Pioneer in Analgesic Compound Innovations
Introduction
Atsusuke Terada is a well-regarded inventor based in Tokyo, Japan, who has made significant contributions to the field of pharmaceuticals, particularly in the development of analgesic compounds. With a remarkable portfolio consisting of 22 patents, Terada's work demonstrates a strong commitment to advancing medical science.
Latest Patents
Among his latest innovations is a patent for a process for preparing analgesic compounds. This process involves a compound wherein specific functional groups are manipulated to develop drugs that provide pain relief. His formulation includes a range of substituents that enhance the compound's therapeutic efficacy. Another notable patent addresses the use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents, showcasing their potential in not only relieving pain but also inhibiting inflammatory processes.
Career Highlights
Terada has built an impressive career with Sankyo Company, Limited, a leading pharmaceutical company known for its innovative drug development. His endeavors to create effective medicinal compounds have positioned him as a key player in the pharmaceutical sector, making strides in pain management and anti-inflammatory therapies.
Collaborations
Throughout his career, Atsusuke Terada has collaborated with several esteemed colleagues, including Kazuyuki Wachi and Yoshio Iizuka. These partnerships have fostered an environment of innovation, leading to breakthroughs in the chemistry of analgesics and enhancing the collective expertise within their field.
Conclusion
Atsusuke Terada's contributions to pharmaceutical innovations, particularly in analgesics, underscore his role as a significant inventor in modern medicine. His ongoing research and development efforts promise to impact pain management and anti-inflammatory treatments profoundly, benefitting countless patients worldwide.